Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 4251-4300 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT06247085
A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
PHASE3
Active, not recruiting
70 participants
Started: Dec 28, 2023 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT06164873
A Study of IBI362 9 mg in Chinese Adults With Obesity
PHASE3
Active, not recruiting
462 participants
Started: Dec 27, 2023 · Completed: Sep 19, 2025
1 condition
1 sponsor
1 location
NCT06160986
Horizons Chronic Graft-Versus-Host-Disease Study
NA
Active, not recruiting
20 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06196541
Respiratory and Physical Functions in Individuals With Chronic Venous Insufficiency
N/A
Active, not recruiting
60 participants
Started: Dec 27, 2023 · Completed: Dec 27, 2026
1 condition
1 sponsor
1 location
NCT06099782
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)
PHASE2
Active, not recruiting
147 participants
Started: Dec 26, 2023 · Completed: Nov 16, 2026
3 conditions
1 sponsor
45 locations
NCT06680466
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery
PHASE2
Active, not recruiting
179 participants
Started: Dec 26, 2023 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT06076135
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors
PHASE2
Active, not recruiting
16 participants
Started: Dec 26, 2023 · Completed: Sep 30, 2026
4 conditions
1 sponsor
1 location
NCT06111846
Study of Human Bone Marrow Mesenchymal Stem Cells in APAP
PHASE2
Active, not recruiting
10 participants
Started: Dec 25, 2023 · Completed: Aug 30, 2026
1 condition
2 sponsors
1 location
NCT06224907
Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A
PHASE3
Active, not recruiting
6 participants
Started: Dec 25, 2023 · Completed: Mar 31, 2029
1 condition
1 sponsor
4 locations
NCT06333210
Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)
PHASE3
Active, not recruiting
421 participants
Started: Dec 25, 2023 · Completed: Feb 29, 2028
1 condition
1 sponsor
32 locations
NCT05913895
The Effect of Hydrogen Water in Oral Mucositis in Head and Neck Cancer Patients After Therapy
NA
Active, not recruiting
30 participants
Started: Dec 24, 2023 · Completed: Oct 31, 2026
4 conditions
1 sponsor
1 location
NCT06466564
Bioabsorbable/Nufairy Coil Application Trial in China
NA
Active, not recruiting
258 participants
Started: Dec 24, 2023 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT06226233
Efficacy of Juniver, a Digital Self-help Intervention, on Symptoms of Eating Disorders: A Randomised Controlled Trial
NA
Active, not recruiting
300 participants
Started: Dec 23, 2023 · Completed: Aug 30, 2025
7 conditions
3 sponsors
1 location
NCT06081361
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort
PHASE3
Active, not recruiting
186 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
39 locations
NCT07107373
A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US
N/A
Active, not recruiting
150 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06289998
Study of Tamibarotene in Patients With ADPKD
PHASE2
Active, not recruiting
70 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
8 locations
NCT06194383
Treatment of Hyperpyrexia and in the Pediatric Emergency Department (FEVER_ED)
N/A
Active, not recruiting
160 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06298643
Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan
N/A
Active, not recruiting
300 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06454526
Effects of Mindfulness-Based Program on Individual and Organizational Output of Frontline Manager Nurses:
NA
Active, not recruiting
41 participants
Started: Dec 21, 2023 · Completed: Jun 30, 2024
2 conditions
1 sponsor
1 location
NCT06219993
Robot-assisted Modified Kasai Portoenterostomy Versus Open Kasai Portoenterostomy for Biliary Atresia
N/A
Active, not recruiting
60 participants
Started: Dec 21, 2023 · Completed: Dec 30, 2025
4 conditions
1 sponsor
2 locations
NCT06122662
AMX0035 and Progressive Supranuclear Palsy
PHASE2/PHASE3
Active, not recruiting
110 participants
Started: Dec 21, 2023 · Completed: Nov 30, 2029
4 conditions
1 sponsor
62 locations
NCT06140836
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
PHASE3
Active, not recruiting
190 participants
Started: Dec 21, 2023 · Completed: Jun 3, 2027
1 condition
2 sponsors
122 locations
NCT06181435
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
PHASE3
Active, not recruiting
589 participants
Started: Dec 21, 2023 · Completed: Mar 17, 2026
1 condition
1 sponsor
142 locations
NCT06273332
Assessment of the Artifical Intelligence Assisted Registration Versus Conventional Point Based Registration on Cone Beam-computed Tomography (CBCT) With Heavy Metal Artifacts
NA
Active, not recruiting
16 participants
Started: Dec 20, 2023 · Completed: Feb 25, 2024
1 condition
1 sponsor
1 location
NCT06180889
Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
PHASE2
Active, not recruiting
241 participants
Started: Dec 20, 2023 · Completed: Apr 15, 2026
1 condition
1 sponsor
1 location
NCT06121635
The Effects of Two Types of t-DCS Stimulation on Robot-assisted Gait Training in Patients With Multiple Sclerosis
NA
Active, not recruiting
36 participants
Started: Dec 20, 2023 · Completed: Jul 30, 2024
2 conditions
1 sponsor
1 location
NCT06234748
Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
PHASE2
Active, not recruiting
19 participants
Started: Dec 20, 2023 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT05839847
LIFU for Anxiety Management
NA
Active, not recruiting
44 participants
Started: Dec 20, 2023 · Completed: Apr 1, 2026
1 condition
1 sponsor
1 location
NCT06175637
Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs
N/A
Active, not recruiting
409 participants
Started: Dec 20, 2023 · Completed: May 30, 2027
1 condition
1 sponsor
25 locations
NCT05883956
A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
PHASE3
Active, not recruiting
13 participants
Started: Dec 20, 2023 · Completed: May 31, 2025
4 conditions
1 sponsor
11 locations
NCT06046950
TrEatment Targets in Rheumatoid Arthritis: TETRA-study
NA
Active, not recruiting
340 participants
Started: Dec 20, 2023 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT06768424
Comparison of MIST With PRF and GBT With PRF in the Treatment of Intrabony Periodontal Defect. A Prospective RCT
NA
Active, not recruiting
36 participants
Started: Dec 20, 2023 · Completed: Dec 20, 2025
1 condition
1 sponsor
1 location
NCT05953389
Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents
PHASE2
Active, not recruiting
62 participants
Started: Dec 20, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
15 locations
NCT06182124
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
PHASE1/PHASE2
Active, not recruiting
558 participants
Started: Dec 20, 2023 · Completed: May 23, 2026
1 condition
1 sponsor
18 locations
NCT06196216
Breast Lesion in CT Chest
N/A
Active, not recruiting
100 participants
Started: Dec 20, 2023 · Completed: Oct 31, 2027
1 condition
1 sponsor
1 location
NCT05999812
Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
PHASE2
Active, not recruiting
22 participants
Started: Dec 19, 2023 · Completed: Oct 1, 2028
1 condition
2 sponsors
1 location
NCT06106295
Metyrapone for Mild Autonomous Cortisol Secretion (MACS)
PHASE2
Active, not recruiting
30 participants
Started: Dec 19, 2023 · Completed: Feb 1, 2028
2 conditions
1 sponsor
1 location
NCT06052137
Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression
NA
Active, not recruiting
16 participants
Started: Dec 19, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05859776
Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
PHASE1/PHASE2
Active, not recruiting
15 participants
Started: Dec 19, 2023 · Completed: May 31, 2025
1 condition
1 sponsor
4 locations
NCT06118411
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
PHASE3
Active, not recruiting
614 participants
Started: Dec 19, 2023 · Completed: Feb 29, 2028
1 condition
1 sponsor
148 locations
NCT06137768
A Trial of HRS-5965 Tablets in Primary IgA Nephropathy
PHASE2
Active, not recruiting
123 participants
Started: Dec 19, 2023 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06055972
Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health
NA
Active, not recruiting
800 participants
Started: Dec 19, 2023 · Completed: Feb 2, 2025
3 conditions
1 sponsor
2 locations
NCT06590844
"cindilizumab + Bevacizumab + Coenzyme I for Injection in Unresectable Hepatocellular Carcinoma"
PHASE4
Active, not recruiting
37 participants
Started: Dec 19, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06168799
Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery
PHASE2
Active, not recruiting
271 participants
Started: Dec 19, 2023 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT06108141
Virtual Reality Intervention to Support Clinicians' Firearm Safety Counseling Behaviors
NA
Active, not recruiting
130 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT06137235
Effects of an Infant Formula and follow-on Formula Containing Bio-active Ingredients on Growth, Tolerance and Infections
NA
Active, not recruiting
456 participants
Started: Dec 18, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
3 locations
NCT05389865
Proximal Aortopathy in Scotland - Epidemiology and Surgical Outcomes
N/A
Active, not recruiting
1,662 participants
Started: Dec 18, 2023 · Completed: Aug 31, 2025
9 conditions
5 sponsors
1 location
NCT06159894
"Implementation of Long-acting Cabotegravir + Rilpivirine Administration Out of HIV Units."
NA
Active, not recruiting
90 participants
Started: Dec 18, 2023 · Completed: Jul 15, 2025
1 condition
1 sponsor
1 location
NCT06499142
STP.168 Clinical Study Protocol Parakeet
NA
Active, not recruiting
60 participants
Started: Dec 18, 2023 · Completed: Jan 31, 2025
4 conditions
1 sponsor
1 location
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
PHASE3
Active, not recruiting
1,314 participants
Started: Dec 18, 2023 · Completed: Dec 2, 2030
2 conditions
2 sponsors
319 locations
Previous
1
More pages
83
84
85
86
87
88
89
More pages
431
Next